CEO of Largest North American Biorefinery Joins Team
January 30 2014 - 8:00AM
Marketwired
CEO of Largest North American Biorefinery Joins Team
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan 30, 2014) -
Calyx Bio-Ventures Inc. (TSX-VENTURE:CYX) ("Calyx" or the
"Company") is pleased to announce that John Plaza has agreed to
join the Company's investee Agrisoma's Board of Directors as Calyx
nominee effective January 20th, 2014. Mr. Plaza brings extensive
biorefinery and executive leadership experience to Agrisoma.
John Plaza is president, CEO and founder of Imperium Renewables
in Seattle, Washington. Mr. Plaza started the company in February
2004 by building the first commercial scale biodiesel production
facility in the western United States. By 2007, Imperium developed,
built and now currently operates Imperium Grays Harbor, one of the
largest biodiesel production facilities in the world at 100 million
gallons per year. The company's core focus was to develop and build
advanced technology for biofuel production that differentiated
itself in the market with fuel quality and scale. This innovative
direction, which was led by Mr. Plaza, facilitated Imperium's
significant growth. Most recently, Imperium has been focused on
renewable jet fuel production platforms. These include building
commercial scale facilities to produce renewable jet fuel, as well
as research and development of future production pathways for
renewable jet fuel from biomass sources. Prior to founding Imperium
Renewables, Mr. Plaza was a commercial airline pilot for 20 years.
John has flown over 17,000 hours in more that 50 different
aircraft, starting his career as a bush pilot in Northern Alaska,
then going on to fly B747, DC-10 and A-320 aircraft for Northwest
Airlines. Mr. Plaza has acted as an Adviser to the Clinton Global
Initiative Americas, 2012 Clean Fuel & Transportation and is a
contributor to the Sustainable Alternative Fuels for Aviation
Expert Group (SUSTAF) created by ICAO. He has been named one of the
top 100 People in Bioenergy the last three years.
"I am excited to be a part of the team for this innovative
company and greatly support their efforts to assist with the
diversification of agricultural products for farmers throughout the
world. The vision and opportunities for the supply of a non-food
oilseed crop like Carinata is of critical importance for the future
of renewable fuels. Biofuels produced from Carinata provide an
important option to meeting the rapid growth in energy demand,
while effectively balancing social and environmental needs," said
John Plaza.
"We are delighted to have John sit as a Calyx nominee on the
Agrisoma Board. John is a well-connected, big vision guy with
industry-leading bioenergy knowledge and the track record to back
it up. His experience in both aviation and biorefining are vital in
the commercialization of carinata," commented Don Konantz, Chief
Executive Officer of Calyx.
About Calyx
Calyx Bio-Ventures Inc. (TSX-VENTURE:CYX) is an agricultural
technology company focused on renewable fuels including biojet and
biodiesel. Calyx is the largest shareholder of Agrisoma Biosciences
Inc., a company which is producing a new proprietary non-food
energy feedstock crop - carinata - which yields oil that can be
refined into fuels that work in existing engines as a 100 percent
petroleum substitute. From seed to sky, fuels produced from
carinata substantially reduce carbon and other harmful emissions,
and help to reduce global petroleum dependence. Carinata was used
to fly the world's first 100% biojet flight, as achievement that
Popular Science called one of the top science events on the planet
in 2012. For further information about Calyx, please visit
www.calyxbio.com. For more information on Agrisoma, please visit
www.agrisoma.com.
Forward-Looking Statements: This document contains certain
forward-looking statements concerning Calyx, as well as other
expectations, plans, goals, objectives, information or statements
about future events, conditions, or performance that may constitute
"forward-looking statements" or "forward-looking information" under
applicable securities legislation. Such statements or
information involve substantial known and unknown risks and
uncertainties, certain of which are beyond Calyx's
control.
Such forward-looking statements or information are based on
a number of assumptions, which may prove to be incorrect.
Although Calyx believes that the expectations reflected in
such forward-looking statements or information are reasonable,
undue reliance should not be placed on forward-looking statements
because Calyx can give no assurance that such expectations will
prove to be correct. Forward-looking statements or information are
based on current expectations, estimates and projections that
involve a number of risks and uncertainties which could cause
actual results to differ materially from those anticipated by Calyx
and described in the forward-looking statements or
information.
The forward-looking statements or information contained in
this news release are made as of the date hereof and Calyx
undertakes no obligation to update publicly or revise any
forward-looking statements or information, whether as a result of
new information, future events or otherwise unless so required by
applicable securities laws or the TSX Venture Exchange. The
forward-looking statements or information contained in this news
release are expressly qualified by this cautionary
statement.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Calyx Bio-Ventures Inc.Don KonantzPresident &
CEO604-649-5961dkonantz@calyxbio.comCalyx Bio-Ventures Inc.Keir
ReynoldsInvestor
Relations778-998-9242kreynolds@calyxbio.comwww.calyxbio.com
Calyx Ventures (TSXV:CYX)
Historical Stock Chart
From Apr 2024 to May 2024
Calyx Ventures (TSXV:CYX)
Historical Stock Chart
From May 2023 to May 2024